At Courage Against Cancer (CAC), our mission is to provide evidence-based answers to the question cancer patients are asking most: does fenbendazole have a real scientific foundation in colorectal cancer research?
Tag: antiparasitic drugs cancer
At Courage Against Cancer (CAC), we believe cancer patients deserve evidence-based answers to the central question driving this article: What are qualified oncologists and researchers actually saying about fenbendazole in 2026? The short answer is nuanced — scientific interest exists, but formal clinical evidence remains limited.
At Courage Against Cancer (CAC), our mission is to provide evidence-based answers to the pressing question: Could fenbendazole play a role in colorectal cancer care? Laboratory research has proposed several biological mechanisms.
Courage Against Cancer announces a major milestone: funding our first preclinical trial for ivermectin and mebendazole. This is the critical first step on our rigorous path to achieve FDA approval and create a new, accessible paradigm in cancer therapy.